SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$8.41M-44.6% | -$7.66M-13.7% | -$6.79M+4.5% | -$6.6M+11.6% | -$5.81M+39.2% | ||
| $798K+58.0% | $447K+19.8% | $503K+32.0% | $501K+50.0% | $505K+6.1% | ||
| $685K+147% | —— | -$1.03M+41.7% | -$441K+58.4% | $277K-84.7% | ||
| -$1.26M+56.3% | —— | —— | -$488K+65.8% | -$2.9M-178% | ||
| $652K-42.4% | —— | $635K— | $291K+334% | $1.13M-53.6% | ||
| $153K+4.1% | $154K+4.1% | $147K+7.3% | $149K+8.0% | $147K+6.5% | ||
| -$159K0.0% | -$159K-17.8% | -$158K-18.8% | -$159K-19.5% | -$159K-20.5% | ||
| -$8.85M+2.5% | -$4.92M+31.2% | -$7.07M+9.5% | -$7.33M+24.3% | -$9.07M+15.7% | ||
| $66K+37.5% | —— | $64K— | —— | $48K— | ||
| —— | $131.75K+723% | $131.75K+723% | $131.75K+723% | $131.75K+723% | ||
| $44.15M+87.2% | $32.39M+404,825% | $26.09M+32.5% | $4.23M+922% | $23.58M-11.5% | ||
| $35.3M+143% | $27.47M— | $19.02M+60.1% | $0— | $14.51M-8.6% | ||
| -$159K0.0% | -$159K-17.8% | -$158K-18.8% | -$159K-19.5% | -$159K-20.5% | ||
| $652K-42.4% | —— | $635K— | $291K+334% | $1.13M-53.6% | ||
| $153K+4.1% | $154K+4.1% | $147K+7.3% | $149K+8.0% | $147K+6.5% | ||
| $0-100% | —— | —— | $21K-64.4% | $23.03M-13.2% | ||
| $66K+37.5% | —— | $64K+36.2% | —— | $48K-5.9% | ||
| $44.08M+8,664% | $3.91M+390,500% | $4M+2,481% | $4.21M+1,086% | $503K+927% | ||
| $0-100% | —— | $41K+156% | -$21K+57.1% | $21K-79.8% | ||
| -$159K0.0% | -$159K-17.8% | -$158K-18.8% | -$159K-19.5% | -$159K-20.5% | ||
| $845K+238% | $597K+230% | $292K+32.1% | $272K+80.1% | $250K+216% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.